PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsHeartburn
MeSH D006356 - heartburn
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012817:Digestive signs and symptoms
0 Companies
0 Drugs
Success rate
D006356: 
Heartburn
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Salix PharmaceuticalsFamotidine Pepcid  1987-02-02   
Omeprazole Zegerid  2004-06-15   
TevaFamotidine Famotidine  2001-04-16   
Famotidine, Ibuprofen Ibuprofen Famotidine  2021-10-29   
Omeprazole Omeprazole  2017-06-13   
Pantoprazole Pantoprazole  2007-08-02   
Rabeprazole Rabeprazole  2013-11-08   
CiplaEsomeprazole Esomeprazole Magnesium  2015-01-26   
Pantoprazole Pantoprazole  2025-03-31   
Glenmark PharmaceuticalsEsomeprazole Esomeprazole Magnesium  2019-05-10   
Famotidine Famotidine  2005-03-07   
Nizatidine Nizatidine  2011-07-15   
Omeprazole Omeprazole  2014-10-31   
IngenusPantoprazole Pantoprazole  2019-03-01   
MylanEsomeprazole Esomeprazole  2017-05-17   
Esomeprazole Esomeprazole Magnesium  2015-08-02   
Famotidine Famotidine  2001-04-18   
Esomeprazole, Naproxen Naproxen Esomeprazole Magnesium  2021-07-20   
Nizatidine Nizatidine  2002-07-05   
Omeprazole Omeprazole  2018-06-29   
Pantoprazole Pantoprazole  2011-01-19   
Rabeprazole sodium Rabeprazole  2013-11-08   
Dexlansoprazole Dexlansoprazole  2024-01-19   
NATCO PharmaFamotidine Famotidine  2001-12-21   
XiromedOmeprazole Omeprazole  2020-12-10   
Johnson & JohnsonFamotidine Pepcid Ac  1995-04-28   
Famotidine, Calcium carbonate Pepcid Complete  2000-10-16   
PerrigoEsomeprazole Esomeprazole Magnesium  2017-08-18   
Famotidine Famotidine  2005-03-18   
Famotidine Famotidine, Carbonate, Magnesium Hydroxide  2008-02-06   
Omeprazole Omeprazole Bicarbonate  2016-07-15   
Omeprazole Omeprazole Magnesium  2015-07-30   
Pantoprazole Pantoprazole  2014-05-07   
1
2
3
4
5
6
...
12
>
Clinical Trials
Historical Success Rate
Phase 1
88%
7/8
Phase 2
71%
5/7
Phase 3
81%
17/21
Approved: 10Overall Success rate: 51%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Mylan
1
2
3
4
5
6
...
8
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use